Intrinsiqq
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. Financials

PBH

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 18 available years
Income Statement
TTM
MAR 2026
MAR 2025
MAR 2024
MAR 2023
MAR 2022
Revenues
Revenue$1,095$1,078$1,138$1,125$1,128$1,087
Cost of Revenue$513$493$503$501$502$466
Gross Profit$591$596$634$624$625$621
General & Administrative$131$116$108$106$107$107
Total Operating Expenses$301$286$298$282$648$291
Operating Income$290$309$337$342-$22$330
Non-Operating
Net Interest Expense––-$2-$5-$4-$64
Other Non-Operating Income (Expense)-$10-$10-$51-$61-$67-$3
EBT (Earnings Before Tax)–$257$284$276-$94$262
Income Tax Expense$62$67$70$67-$12$57
Net Income
Net Income$172$190$215$209-$82$205
Per Share Data
Revenue Per Share$22.99$22.13$22.72$22.43$22.60$21.38
EPS (Basic)$3.58$3.93$4.32$4.21-$1.65$4.09
EPS (Diluted)$3.57$3.91$4.29$4.17-$1.65$4.04
Weighted Avg Shares (Basic)47.5M48.5M49.7M49.8M49.9M50.3M
Weighted Avg Shares (Diluted)47.6M48.7M50.1M50.2M49.9M50.8M
Shares Outstanding47.6M48.7M50.1M50.2M49.9M50.8M

Prestige Consumer Healthcare (PBH) financials: revenue, profit and margins

Prestige Consumer Healthcare (PBH) generated about $1.1 billion in revenue and $172 million in net income (a 15.7% net margin) over the trailing twelve months, growing at roughly 2.7% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Prestige Consumer Healthcare's (PBH) revenue?+

Prestige Consumer Healthcare generated about $1.1 billion in revenue over the trailing twelve months. Revenue has grown at roughly 2.7% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Prestige Consumer Healthcare profitable?+

Yes, Prestige Consumer Healthcare reported about $172 million in net income over the trailing twelve months, a net profit margin of roughly 15.7%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Prestige Consumer Healthcare's profit margins?+

Prestige Consumer Healthcare runs a gross margin of about 54.0%, an operating margin of about 26.5%, a net margin of about 15.7%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Prestige Consumer Healthcare growing?+

Prestige Consumer Healthcare's revenue has compounded at roughly 2.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside PBH's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 19 Sept 2026. How this is calculated.

Fiscal year ends Mar.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PBH

CompareIntrinsic value
APLSApellis Pharmaceuticals, Inc.
$3.10+3.29%83
ACADAcadia Pharmaceuticals Inc.
$21.49+4.47%74
PTCTPTC Therapeutics, Inc.
$68.97+1.25%65
ANIPAni Pharmaceuticals Inc.
$72.89+0.84%85
HRMYHarmony Biosciences Holdings, Inc.
$34.42-7.04%82
MDGLMadrigal Pharmaceuticals, Inc.
$400.67+1.10%10
IONSIonis Pharmaceuticals, Inc.
$40.15-0.67%39
INDVIndivior Pharmaceuticals, Inc.
$36.28+2.57%80

Held by ETFs

PBH is in 96 US ETFs. The largest of them, with PBH's weight in each:

Spot a number that looks wrong? Check it in PBH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PBH

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.